BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BloombergQuint’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
To strengthen its specialty chemicals division and for growth, Navin Fluorine International Ltd. announced Rs 1.95 billion capex in agro and pharma, expected to be funded through internal accruals and debt.
The multi-purpose plant at its wholly-owned subsidiary, Navin Fluorine Advanced Sciences Ltd., at Dahej, Gujarat, is expected to be commissioned in H1 FY23, with approximately 1.4 times asset turnover.
The expansion would help launch products of complex fluorinated chemistry and strengthening customer relations.
Click on the attachment to read the full report:
This report is authored by an external party. BloombergQuint does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of BloombergQuint.
Users have no license to copy, modify, or distribute the content without permission of the Original Owner.